Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous Temozolomide in Advanced Breast Cancer or Soft Tissue Sarcoma
NCT00194766Phase 2Completed
- Sponsor
- University of Washington
- Start
- Jul 2000
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of temozolomide in breast cancer and soft tissue sarcoma (STS), sponsored by University of Washington. Primary endpoint: Response Rate. Started Jul 2000; status: completed.
02
Drugs
temozolomide
03
Conditions
breast cancersoft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT00194766.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00194766.